The prime time for management of hepatocellular carcinoma in Hong Kong

por Chan, Landon L., Chan, Stephen L.
Publicado 2023

The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment

por Chan, Landon L., Chan, Stephen L.
Publicado 2023

Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma

por Chan, Landon L., Chan, Stephen L.
Publicado 2022

Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond

por Feng, Maple Ye, Chan, Landon L., Chan, Stephen Lam
Publicado 2022

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma

por Chan, Stephen L., Cheng, Paul N.M., Liu, Angela M., Chan, Landon L., Li, Leung, Chu, Cheuk M., Chong, Charing C.N., Lau, Yat M., Yeo, Winnie, Ng, Kelvin K.C., Yu, Simon C.H., Mok, Tony S.K., Chan, Anthony W.H.
Publicado 2021

Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation

por Lou, Shaoke, Lee, Heung-Man, Qin, Hao, Li, Jing-Woei, Gao, Zhibo, Liu, Xin, Chan, Landon L, KL Lam, Vincent, So, Wing-Yee, Wang, Ying, Lok, Si, Wang, Jun, Ma, Ronald CW, Tsui, Stephen Kwok-Wing, Chan, Juliana CN, Chan, Ting-Fung, Yip, Kevin Y
Publicado 2014